Cancer Risk in Primary Biliary Cirrhosis: A Population–Based Study From Sweden
Lars Lööf, Hans‐Olov Adami, Pär Sparén et al. · Hepatology · 1994
A cohort of 559 patients in Sweden who satisfied predetermined criteria for the diagnosis of primary biliary cirrhosis was followed with respect to the incidence of cancer during the period of 1958 to 1988. The mean follow-up time from the time of primary biliary cirrhosis diagnosis was 9.0 +/- 5.4 yr. During the follow-up period, 148 patients died and the primary cause of death was liver insufficiency. An overall excess risk for cancer, standardized incidence ratio 1.6; 95% confidence interval, 1.1 to 2.2, was found in the cohort. In contrast to previous reports, we found no excess risk for breast cancer (standardized incidence ratio, 0.9; 95% confidence interval, 0.3 to 2.1). The number of hepatocellular cancers in the primary biliary cirrhosis cohort did not significantly differ from expected (standardized incidence ratio, 2.91; 95% confidence interval, 0.4 to 10.5).
Cited by 83 works. doi:10.1002/hep.1840200116 Open-access PDF
Authors
- Lars Lööf
- Hans‐Olov Adami
- Pär Sparén
- Åke Danielsson
- Ljusk Siw Eriksson
- Rolf W. Hultcrantz
- Stefan C. Lindgren
- Rolf Olsson
- Hanne Prytz
- Bengt-Olof Rydén
- Hanna Sandberg–Gertzén
- Sven Wallerstedt
References
- Increased Risk of Lymphoma in Sicca Syndrome
- Relationship Between Hepatocellular Carcinoma and Cirrhosis
- Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus
- A multifactorial model for pancreatic cancer in man. Epidemiologic evidence
- Diabetes mellitus and cancer risk: A multisite case-control study
- Pancreatic cancer, alcohol, diabetes mellitus and gall‐bladder disease
- Alcoholism and liver cirrhosis in the etiology of primary liver cancer
- Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis.
- Cancer mortality in patients with rheumatoid arthritis.
- The Prevalence and Clinical Spectrum of Primary Biliary Cirrhosis in a Defined Population